QQQ $ 444.73 $ 1.02 (0.23 %)
DIA $ 395.15 $ -0.72 (-0.18 %)
SPY $ 522.25 $ 0.07 (0.01 %)
TLT $ 90.61 $ 0.23 (0.26 %)
GLD $ 217.45 $ -2.45 (-1.12 %)
$ 0.0191
-- x --
-- x --
-- - --
$ 0.01 - $ 0.22
5,000
na
na
$ -8.76
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psychedelics-headlines-anti-inflammatory-effects-global-drug-survey-synthetic-surprise-uks-harm-reduction-hub-and-more

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and onli...

 how-to-finance-a-psychedelics-business-learn-from-these-four-companies

Clearmind Medicine Announces Pricing of $3.5 Million Public Offering

 psyched-australia-as-psychedelics-hub-advanced-scans-of-brain-on-dmt-new-pac-for-congressional-influence-9-states-advancing-bills--more

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

 psychedelic-research-expands-in-australia-with-palliative-care-partnership--new-mdma-analog-portfolio

Psyence Partners with iNGENū for Palliative Care Clinical Trial

 psychedelics-update-mdma-export-3d-farm-recovery-center-reopens-mushroom-extraction--e-commerce

Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its m...

 psychedelics-travel-clinical-grade-magic-mushrooms-extract-exported-from-southern-africa-to-uk

Lifesciences psychedelics biotech Psyence Group Inc. (OTCQB: PSYGF) recently exported purified pharmaceutical-grade psilocybin ...

 6-psychedelics-companies-take-action-here-are-the-latest-major-announcements

Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in ...

Core News & Articles

Psyence Group Inc.

 psyched-first-ayahuasca-pill-created-psychedelics-legalization-predicted-uks-research-support-and-more

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedel...

 psyence-revive-therapeutics-ink-private-placements-capital-to-support-drug-trials

Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private place...

 psychedelics-company-filament-signs-licensing-deal-with-psyence-in-us-uk-and-eu

Filament Health Corp. (OTCQB: FLHLF) and Psyence Group Inc. (OTCQB: PSYGF) have inked a worldwide commercial licensing deal.

 european-psychedelics-research-group-nabs-2m-in-seed-funding-as-clinical-research-picks-up-speed

UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing th...

 international-magic-mushrooms-where-are-they-produced-and-where-are-they-headed

Psyence Group Inc.

 magic-mushrooms-vs-psychotherapy-for-incurable-cancer-diagnosis-moves-forward-in-uk-clinical-trials

UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Psyence Group Inc.

 psyched-big-pharmas-sanofi-enters-psychedelics-space-dna-from-80-psilocybe-mushrooms-published-online-maine-psychedelics-bill-shelved

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry execu...

 psyence-filament-strike-magic-mushroom-product-licensing-agreement-what-you-need-to-know

Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION